556 related articles for article (PubMed ID: 21907221)
1. Signaling pathways underlying the rapid antidepressant actions of ketamine.
Duman RS; Li N; Liu RJ; Duric V; Aghajanian G
Neuropharmacology; 2012 Jan; 62(1):35-41. PubMed ID: 21907221
[TBL] [Abstract][Full Text] [Related]
2. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists.
Duman RS; Li N
Philos Trans R Soc Lond B Biol Sci; 2012 Sep; 367(1601):2475-84. PubMed ID: 22826346
[TBL] [Abstract][Full Text] [Related]
3. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Li N; Lee B; Liu RJ; Banasr M; Dwyer JM; Iwata M; Li XY; Aghajanian G; Duman RS
Science; 2010 Aug; 329(5994):959-64. PubMed ID: 20724638
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
Deyama S; Duman RS
Pharmacol Biochem Behav; 2020 Jan; 188():172837. PubMed ID: 31830487
[TBL] [Abstract][Full Text] [Related]
5. Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants.
Dwyer JM; Duman RS
Biol Psychiatry; 2013 Jun; 73(12):1189-98. PubMed ID: 23295207
[TBL] [Abstract][Full Text] [Related]
6. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.
Voleti B; Navarria A; Liu RJ; Banasr M; Li N; Terwilliger R; Sanacora G; Eid T; Aghajanian G; Duman RS
Biol Psychiatry; 2013 Nov; 74(10):742-9. PubMed ID: 23751205
[TBL] [Abstract][Full Text] [Related]
7. Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function.
Duman RS; Shinohara R; Fogaça MV; Hare B
Mol Psychiatry; 2019 Dec; 24(12):1816-1832. PubMed ID: 30894661
[TBL] [Abstract][Full Text] [Related]
8. Spine synapse remodeling in the pathophysiology and treatment of depression.
Duman CH; Duman RS
Neurosci Lett; 2015 Aug; 601():20-9. PubMed ID: 25582786
[TBL] [Abstract][Full Text] [Related]
9. GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine.
Miller OH; Yang L; Wang CC; Hargroder EA; Zhang Y; Delpire E; Hall BJ
Elife; 2014 Oct; 3():e03581. PubMed ID: 25340958
[TBL] [Abstract][Full Text] [Related]
10. GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine.
Liu RJ; Duman C; Kato T; Hare B; Lopresto D; Bang E; Burgdorf J; Moskal J; Taylor J; Aghajanian G; Duman RS
Neuropsychopharmacology; 2017 May; 42(6):1231-1242. PubMed ID: 27634355
[TBL] [Abstract][Full Text] [Related]
11. Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine.
Wohleb ES; Gerhard D; Thomas A; Duman RS
Curr Neuropharmacol; 2017; 15(1):11-20. PubMed ID: 26955968
[TBL] [Abstract][Full Text] [Related]
12. Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions.
Fuchikami M; Thomas A; Liu R; Wohleb ES; Land BB; DiLeone RJ; Aghajanian GK; Duman RS
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8106-11. PubMed ID: 26056286
[TBL] [Abstract][Full Text] [Related]
13. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
Liu RJ; Fuchikami M; Dwyer JM; Lepack AE; Duman RS; Aghajanian GK
Neuropsychopharmacology; 2013 Oct; 38(11):2268-77. PubMed ID: 23680942
[TBL] [Abstract][Full Text] [Related]
14. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
Li N; Liu RJ; Dwyer JM; Banasr M; Lee B; Son H; Li XY; Aghajanian G; Duman RS
Biol Psychiatry; 2011 Apr; 69(8):754-61. PubMed ID: 21292242
[TBL] [Abstract][Full Text] [Related]
15. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.
Tang J; Xue W; Xia B; Ren L; Tao W; Chen C; Zhang H; Wu R; Wang Q; Wu H; Duan J; Chen G
Sci Rep; 2015 Aug; 5():13573. PubMed ID: 26315757
[TBL] [Abstract][Full Text] [Related]
16. New Hippocampal Neurons Mature Rapidly in Response to Ketamine But Are Not Required for Its Acute Antidepressant Effects on Neophagia in Rats.
Soumier A; Carter RM; Schoenfeld TJ; Cameron HA
eNeuro; 2016; 3(2):. PubMed ID: 27066531
[TBL] [Abstract][Full Text] [Related]
17. The role of mTOR in depression and antidepressant responses.
Abelaira HM; Réus GZ; Neotti MV; Quevedo J
Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
[TBL] [Abstract][Full Text] [Related]
18. Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine.
Deyama S; Kaneda K
Neuropharmacology; 2023 Feb; 224():109335. PubMed ID: 36403852
[TBL] [Abstract][Full Text] [Related]
19. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
[TBL] [Abstract][Full Text] [Related]
20. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
